Comparison of IL-6 versus IL-1 inhibition in cytokine storm of COVID 19: In a cohort study performed by Cavalli et al. (2021), IL-1 and IL-6 inhibition were compared with standard management in patients with COVID-19 developing respiratory insufficiency and hyperinflammation. Here, IL1B is linked to COVID-19.